Keywords: double-digit, turnover, growth, novartis, switzerland, reported, sales
Double-digit turnover growth for Novartis
Article | 11 October 2001
Novartis of Switzerland has reported a sales increase of 11% for thefirst nine months of 2001 to 23.70 billion Swiss francs ($14.73 billion), driven ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
